Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Nancy Kelley, Joachim Schorr

Premium

Nancy Kelley has stepped down from her post as founding executive director of the New York Genome Center. Kelley had been the driving force behind the center's creation and last November had also taken on the role of chief operating officer. As reported by PGx Reporter sister publication In Sequence, Kelley will continue to serve as an advisor and remain on the center's board of directors.


Caris Life Sciences has named Joachim Schorr to be its chief scientific officer.

Schorr formerly worked for two decades at Qiagen, where he was senior vice president of global research and development, managing director, and a member of the executive committee, among other positions. He will continue to serve as a scientific consultant for Qiagen.

Prior to joining Qiagen, Schorr worked at Hoechst, a German chemical-pharmaceuticals company, and was also co-founder of Coley Pharmaceuticals, EnPharma Pharmaceuticals, and QBM Cell Sciences.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.